Ambroxol lozenge bioavailability : an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy thai volunteers.

MLA

Rojpibulstit, Malee, et al. “Ambroxol Lozenge Bioavailability : An Open-Label, Two-Way Crossover Study of the Comparative Bioavailability of Ambroxol Lozenges and Commercial Tablets in Healthy Thai Volunteers.” Clinical Drug Investigation, vol. 23, no. 4, 2003, pp. 273–80. EBSCOhost, https://doi.org/10.2165/00044011-200323040-00007.

APA

Rojpibulstit, M., Kasiwong, S., Juthong, S., Phadoongsombat, N., & Faroongsarng, D. (2003). Ambroxol lozenge bioavailability : an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy thai volunteers. Clinical Drug Investigation, 23(4), 273–280. https://doi.org/10.2165/00044011-200323040-00007

Chicago

Rojpibulstit, Malee, Srirat Kasiwong, Siwasak Juthong, Narubodee Phadoongsombat, and Damrongsak Faroongsarng. 2003. “Ambroxol Lozenge Bioavailability : An Open-Label, Two-Way Crossover Study of the Comparative Bioavailability of Ambroxol Lozenges and Commercial Tablets in Healthy Thai Volunteers.” Clinical Drug Investigation 23 (4): 273–80. doi:10.2165/00044011-200323040-00007.